Cargando…

DNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancers

Death-associated protein kinase is a positive regulator of programmed cell death induced by interferon γ. To investigate the role of epigenetic inactivation of death-associated protein kinase in gastrointestinal cancer, we examined the methylation status of the 5′ CpG island of the death-associated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Satoh, A, Toyota, M, Itoh, F, Kikuchi, T, Obata, T, Sasaki, Y, Suzuki, H, Yawata, A, Kusano, M, Fujita, M, Hosokawa, M, Yanagihara, K, Tokino, T, Imai, K
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2002
Materias:	Experimental Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375414/ https://www.ncbi.nlm.nih.gov/pubmed/12087472 http://dx.doi.org/10.1038/sj.bjc.6600319

Ejemplares similares

Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-γ in haematopoietic tumour cells
por: Morimoto, Y, et al.
Publicado: (2004)

Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-γ in haematopoietic tumour cells
por: Morimoto, Y, et al.
Publicado: (2004)

Histone deacetylation promotes transcriptional silencing at facultative heterochromatin
por: Watts, Beth R, et al.
Publicado: (2018)

Aberrant DNA methylation associated with silencing BNIP3 gene expression in haematopoietic tumours
por: Murai, M, et al.
Publicado: (2005)

Cytoplasmic RASSF2A is a proapoptotic mediator whose expression is epigenetically silenced in gastric cancer
por: Maruyama, Reo, et al.
Publicado: (2008)

A novel method, digital genome scanning detects KRAS gene amplification in gastric cancers: involvement of overexpressed wild-type KRAS in downstream signaling and cancer cell growth
por: Mita, Hiroaki, et al.
Publicado: (2009)

Histone deacetylation: Establishing a meiotic histone code
por: De La Fuente, Rabindranath
Publicado: (2014)

Histone deacetylation regulates de novo shoot regeneration
por: Temman, Haruka, et al.
Publicado: (2023)

Understanding histone deacetylation in Huntington’s disease
por: Valor, Luis Miguel
Publicado: (2016)

Histone acetylation and deacetylation in ischemic stroke
por: Uzdensky, Anatoly B., et al.
Publicado: (2021)

Reply: CIITA methylation and decreased levels of HLA-DR in tumour progression
por: Morimoto, Y, et al.
Publicado: (2004)

Histone H4 deacetylation plays a critical role in early gene silencing during neuronal apoptosis
por: Pelzel, Heather R, et al.
Publicado: (2010)

Histone deacetylation of NIS promoter underlies BRAF V600E-promoted NIS silencing in thyroid cancer
por: Zhang, Zongjing, et al.
Publicado: (2014)

The novel microtubule-interfering agent TZT-1027 enhances the anticancer effect of radiation in vitro and in vivo
por: Akashi, Y, et al.
Publicado: (2007)

Histone deacetylation - a new epigenetic target in cancer
por: Carvalho, João A, et al.
Publicado: (2010)

Vascular histone deacetylation by pharmacological HDAC inhibition
por: Rafehi, Haloom, et al.
Publicado: (2014)

Histone Deacetylation Inhibitors as Therapy Concept in Sepsis
por: von Knethen, Andreas, et al.
Publicado: (2019)

Histone Deacetylation Inhibitors as Modulators of Regulatory T Cells
por: von Knethen, Andreas, et al.
Publicado: (2020)

The association of DNA-dependent protein kinase activity of peripheral blood lymphocytes with prognosis of cancer
por: Someya, M, et al.
Publicado: (2011)

Histone deacetylase 3 regulates microglial function through histone deacetylation
por: Meleady, Laura, et al.
Publicado: (2023)

Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status
por: Akashi, Y, et al.
Publicado: (2008)

Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma
por: Fiaschetti, G, et al.
Publicado: (2014)

Protoporphyrin IX enhancement by 5-aminolaevulinic acid peptide derivatives and the effect of RNA silencing on intracellular metabolism
por: Bourré, L, et al.
Publicado: (2009)

Therapeutic Targeting of Histone Deacetylation to Prevent Alzheimer’s Disease
por: Chacko, Sophia, et al.
Publicado: (2021)

Debating DAP12
por: Van Epps, Heather L.
Publicado: (2005)

Suppressor of Cytokine Signaling (SOCS) Genes Are Silenced by DNA Hypermethylation and Histone Deacetylation and Regulate Response to Radiotherapy in Cervical Cancer Cells
por: Kim, Moon-Hong, et al.
Publicado: (2015)

Apollon gene silencing induces apoptosis in breast cancer cells through p53 stabilisation and caspase-3 activation
por: Lopergolo, A, et al.
Publicado: (2009)

X-chromosome-linked inhibitor of apoptosis as a key factor for chemoresistance in clear cell carcinoma of the ovary
por: Miyamoto, M, et al.
Publicado: (2014)

Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma
por: Erlich, R B, et al.
Publicado: (2012)

Potentiation of apoptosis by histone deacetylase inhibitors and doxorubicin combination: cytoplasmic cathepsin B as a mediator of apoptosis in multiple myeloma
por: Cheriyath, V, et al.
Publicado: (2011)

Stepwise progression of β-selection during T cell development involves histone deacetylation
por: Chann, Anchi S, et al.
Publicado: (2022)

Enhancement of radiosensitivity by a unique novel NF-κB inhibitor, DHMEQ, in prostate cancer
por: Kozakai, N, et al.
Publicado: (2012)

Selective cyclooxygenase-2 silencing mediated by engineered E. coli and RNA interference induces anti-tumour effects in human colon cancer cells
por: Strillacci, A, et al.
Publicado: (2010)

POWERDRESS-mediated histone deacetylation is essential for thermomorphogenesis in Arabidopsis thaliana
por: Tasset, Celine, et al.
Publicado: (2018)

Acetylation and deacetylation of histone in adipocyte differentiation and the potential significance in cancer
por: Wang, Xiaorui, et al.
Publicado: (2023)

R306465 is a novel potent inhibitor of class I histone deacetylases with broad-spectrum antitumoral activity against solid and haematological malignancies
por: Arts, J, et al.
Publicado: (2007)

Efficacy of immunoliposomes on cancer models in a cell-surface-antigen-density-dependent manner
por: Hosokawa, S, et al.
Publicado: (2003)

Prevention of inflammation-mediated acquisition of metastatic properties of benign mouse fibrosarcoma cells by administration of an orally available superoxide dismutase
por: Okada, F, et al.
Publicado: (2006)

Gefitinib treatment affects androgen levels in non-small-cell lung cancer patients
por: Nishio, M, et al.
Publicado: (2005)

UHRF1 depletion and HDAC inhibition reactivate epigenetically silenced genes in colorectal cancer cells
por: Niinuma, Takeshi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_osd8qhmo237btp0v7rj2796mrb